CCMI
IDXX icon

Creative Capital Management Investments’s Idexx Laboratories IDXX Stock Holding History

Creative Capital Management Investments’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.69K Buy
+7
New +$3.93K ﹤0.01% 535

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Creative Capital Management Investments's IDXX Position: Q2 2026 in Review

Creative Capital Management Investments opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 7 shares worth $3.69K. The stake represents ﹤0.01% of the portfolio and ranks #535 among its holdings.

330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Creative Capital Management Investments held 7 shares of Idexx Laboratories worth $3.69K as of Q2 2026.
  • Idexx Laboratories was a new Creative Capital Management Investments position in Q2 2026.
  • Idexx Laboratories made up ﹤0.01% of Creative Capital Management Investments's portfolio in Q2 2026, its #535 holding.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.